Drug Discovery & Development

Conferences & Courses
Drug Discovery Chemistry Drug Discovery Chemistry
April 23-25, 2014 | San Diego, CA

Anti-Inflammatories: Small Molecule Approaches Anti-Inflammatories: Small Molecule Approaches
April 23-24, 2014 | San Diego, CA
JAK kinase inhibitors will probably be the first new class of oral anti-inflammatories on the market, with the first one likely to receive approval end of 2012.

Protein-Protein Interactions Protein-Protein Interactions
April 23-24, 2014 | San Diego, CA
Cambridge Healthtech Institute' s conference on Protein-Protein Interactions has established itself as a successful and well attended event year after year.




Life Science Media Library
Integrating Human Factors Engineering (HFE) into Drug Delivery Integrating Human Factors Engineering (HFE) into Drug Delivery
January 22, 2013 |
In this DVD, we will provide a baseline understanding of the regulatory need, common practices and real world examples of integrating Human Factors Engineering into a drug development activity. Key topics to be addressed: Why you should care: Regulatory expectations for the application of HFE What to avoid: Right and wrong ways to apply HFE to your project Lessons from the field: Real world examples of HFE
First Principles in Binding Kinetics First Principles in Binding Kinetics
June 6, 2012 |
This course will address the questions on “why should I care about kinetics?” and “how can I understand and predict Structure-Kinetics relationships?” We will first review the role of binding kinetics in drug action and then focus on the particular case of protein-ligand non-covalent complexes, reviewing what is known so far about the structural determinants of binding kinetics. This course will help you with a better understanding and increased awareness of current state of the chemistry and pharmacology of binding kinetics.
Pharmacology and Drug Discovery in the Allosteric World Pharmacology and Drug Discovery in the Allosteric World
November 3, 2011 |
The advancing technology of high-throughput screening is changing the type of molecules found. With protein function more physiologically relevant, the quality of the molecules that pharmacologists and medicinal chemists must deal with is changing. This course will familiarize researchers with the tools needed to exploit this potentially fruitful area of new drug discovery through discussion of allosteric molecules, detection of allosterism, and quantifying allosterism for chemical lead optimization.




Publications, Reports, & Whitepapers
Epigenetics: Emerging Targets, Available Technologies, Expert Interviews, and an Epigenetic Community Perspective
Epigenetics: Emerging Targets, Available Technologies, Expert Interviews, and an Epigenetic Community Perspective provides an overview of the scientific and technological landscape from which both the diagnostic and therapeutic sectors of the nascent epigenetics industry are emerging, plus a qualitative analysis of the scientific, technological, and commercial achievements and challenges facing both sectors.